We examined the effects of 2 months of psyllium treatment in optimizing metabolic control and lipoprotein profile, and its postprandial effects on lipids in type II diabetes. We recruited 40 type II diabetic patients who were on sulfonylureas and a controlled diet, sequentially assigning them to psyllium treatment (G1) or to a control group (G2) treated with dietary measures alone. After 2 months of treatment, body mass index, waist circumference, HbA1c (hemoglobin A1c) and fasting plasma glucose levels had significantly decreased in both groups. There were no postprandial differences in the lipoprotein profile between the two groups. Triglycerides were significantly lower in G1, but not in G2. Our study contributes toward elucidating the effects of psyllium on serum lipids, and suggests that psyllium treatment may help in reducing triglycerides (a known risk factor for cardiovascular disease) in type II diabetic patients.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Anderson JW, Allgood LD, Lawrence A, Altringer LA, Jerdack GR, Hengehold DA et al. (2000). Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 71, 472–479.
Clark CA, Gardiner J, McBurney MI, Anderson S, Weatherspoon LJ, Henry DN et al. (2006). Effects of breakfast meal composition on second meal metabolic responses in adults with type 2 diabetes mellitus. Eur J Clin Nutr 60, 1122–1129.
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
Jarjis HA, Blackburn NA, Redfern JS, Read NW (1984). The effect of ispaghula (Fybogel and Metamucil) and guar gum on glucose tolerance in man. Br J Nutr 51, 371–378.
Jaynes PK, Willis MC, Chou PP (1985). Evaluation of a mini-column chromatographic procedure for the measurement of haemoglobin A1c. Clin Biochem 18, 32–36.
Lipid Research Clinics Program (1982). Lipid and lipoprotein analyses. Hainline A, Karon J, Lippel K (eds). In: Manual of Laboratory Operations, 2nd edn, US Department of Health and Human Service: Washington, DC. pp 63–77.
Neal GW, Balm TK (1990). Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia. S Med J 83, 1131–1137.
Rodriguez-Moran M, Guerrero-Romero F, Lazcano-Burciaga GJ (1998). Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications 12, 273–278.
Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP, Farmafibra Group (2002). Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr 56, 830–842.
Van Rosendaal GMA, Shaffer EA, Alun LE, Brant R (2004). Effect of administration on cholesterol-lowering by psyllium: a randomized cross-over study in normocholesterolemic or slightly hypercholesterolemic subjects. Nutr J 28, 3–17.
Wahlefeld AW (1976). Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HU (ed). Methods of Enzymatic Analyses. Academic Press: New York. pp 1831–1835.
About this article
Cite this article
Sartore, G., Reitano, R., Barison, A. et al. The effects of psyllium on lipoproteins in type II diabetic patients. Eur J Clin Nutr 63, 1269–1271 (2009). https://doi.org/10.1038/ejcn.2009.60
- type 2 diabetes
- dietary fiber